C-BRIDGE CAPITAL
C-Bridge Capital Partners identifies and unlocks opportunities to drive growth and development across borders. They leverage their expertise in the United States, China and Israel to help their global clients form international strategic alliances that achieve maximum returns. Using their unparalleled network and extensive knowledge, They facilitate cross-border investments and asset formation in the US, China and Israel. They remain involved to monitor and protect their clients’ investment interests.
C-BRIDGE CAPITAL
Social Links:
Founded:
2014-01-01
Status:
Active
Contact:
212 705 5001
Email Addresses:
[email protected]
Technology used in webpage:
Nginx Shockwave Flash Embed Baidu Analytics Dingfeng Xinhui
Similar Organizations
BioVenture
BioVenture is a Chinese venture capital firm that offers early and growth stage investment services.
Frazier Healthcare Partners
Frazier Healthcare Partners is a healthcare investment firm for pharmaceuticals, healthcare services, & medical products.
New Enterprise Associates
New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Syno Capital
Syno Capital is a principal investment firm focused on life science and healthcare sector investments in New York.
Third Point Ventures
Third Point Ventures is an investment firm that focuses on enterprise, fintech, mobile, and healthcare innovation.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-04-26 | RVAC Medicines | C-Bridge Capital investment in Series B - RVAC Medicines | 140 M USD |
| 2021-05-26 | NiKang Therapeutics | C-Bridge Capital investment in Series C - NiKang Therapeutics | 200 M USD |
| 2021-04-28 | Adcentrx Therapeutics | C-Bridge Capital investment in Series A - Adcentrx Therapeutics | 50 M USD |
| 2020-12-07 | Nuance Biotech | C-Bridge Capital investment in Series D - Nuance Biotech | 181 M USD |
| 2019-08-20 | GrayBug | C-Bridge Capital investment in Series C - GrayBug | 80 M USD |
| 2018-06-29 | I-Mab Biopharma | C-Bridge Capital investment in Series C - I-Mab Biopharma | 220 M USD |
| 2018-06-28 | Nuance Biotech | C-Bridge Capital investment in Series B - Nuance Biotech | 20 M USD |
| 2018-04-23 | CMLabs | C-Bridge Capital investment in Series C - CMLabs | 15.9 M USD |
| 2018-04-02 | CMAB BioPharm | C-Bridge Capital investment in Series B - CMAB BioPharm | 34 M USD |
| 2018-01-02 | CMAB BioPharm | C-Bridge Capital investment in Series A - CMAB BioPharm | 38 M USD |
More informations about "C-Bridge Capital"
CBC Group - Wikipedia
The firm was founded in 2014 as C-Bridge Capital in Shanghai with a focus on private equity investments in China's healthcare sector. The firm was partially backed by Temasek Holdings. C-Bridge Capital would later be rebranded to CBC Group and moved its headquarters to Singapore. CBC primarily invests in late stage companies that already have commercially proven projects which have passed clinical trials. However it has also funded healthcare Startup Companies with …See details»
C-Bridge Capital - Crunchbase Investor Profile
C-Bridge Capital invests in early-stage companies, focusing on healthcare, biotechnology, and medical industries, with a geographical emphasis on Asia and North America. ... 2,678 Number of Organizations • $103.8B Total Funding …See details»
CBC Group
CBC Group’s R-Bridge Healthcare Fund Exits US$60 Million Investment in Paratek. Read More. 2023-10-21 / CBC. ... CBC Group wins PE Deal of the Year 2022 from the Singapore Venture & Private Capital Association. Read More. …See details»
C-Bridge Capital - Nature
C-Bridge Capital Strategic Organization and Portfolio Portfolio & Capital Management ... C-BRIDGE CAPITAL Growth Investments Technology Transfer Consolidation / Buyout rma h s …See details»
C-Bridge Capital - Investments, Portfolio & Company Exits
C-Bridge Capital 's most notable exits include I-Mab Biopharma, LakeShore Biopharma, and Clarus Therapeutics. Which industries has this organization had the most exits in? Show . I …See details»
CBC Group - Overview, News & Similar companies | ZoomInfo.com
Nov 13, 2023 CBC Group (formerly C-Bridge Capital) is one of the largest and most active healthcare-dedicated investment firms in Asia focused on platform-build ing and buyout …See details»
Investing in China’s health care opportunity - Nature
C-Bridge Capital is the leading health care private equity fund in China, focused on investment oppor - ... turing organization (CDMO) that provides process development and manufacturing …See details»
Michael Keyoung | Council of Korean Americans
Dr. Keyoung is Managing Director and Head of North America for CBC Group, formerly known as C-Bridge Capital, a leading healthcare Private Equity firm. Dr. Keyoung is also Founding …See details»
C-Bridge Capital Reaches US$400 Million First Close for Third …
Jul 5, 2018 An independent, non-profit organization, the association brings together 300+ firms—including institutional investors, fund managers, and industry advisors—who manage …See details»
C-Bridge Capital - Funding, Financials, Valuation & Investors
C-Bridge Capital has raised a total of $3B across 5 funds, their latest being C-Bridge Healthcare Fund V. This fund was announced on Jan 1, 2021 and raised a total of obfuscatedSee details»
C-Bridge Capital — 7 Deals, 4 Portfolio startups, Statistics — …
Opposing the other organizations, this C-Bridge Capital works on 12 percentage points less the average amount of lead investments. The higher amount of exits for fund were in 2018. When …See details»
Healthcare firm CBC eyes global expansion after closing flagship …
Apr 1, 2022 CBC Group, the global asset manager formerly known as C-Bridge, is on a mission to become the world’s largest investment firm dedicated to healthcare after closing its latest …See details»
C-Bridge Capital Expands Global Strategic Leadership Team
Oct 9, 2017 C-Bridge Capital is a healthcare dedicated private equity firm, focused on growth and late stage investment opportunities with US$700 million of Assets Under Management. C …See details»
C-Bridge Capital Forms AffaMed Therapeutics to Accelerate
Feb 11, 2019 AffaMed was founded and funded by C-Bridge Capital in 2019. About C-Bridge Capital. C-Bridge Capital is a healthcare dedicated private equity firm, focused on growth and …See details»
C-Bridge hits $400m first close on China healthcare fund - AVCJ
Nov 10, 2023 C-Bridge Capital has reached a first close of just over $400 million on its third healthcare fund, which focuses on Chinese pharmaceutical, medical technology and …See details»
C-Bridge Capital - Investments, Portfolio & Company Exits
Dec 5, 2022 C-Bridge Capital 's most notable exits include I-Mab Biopharma and Ascletis. Which industries has this organization had the most exits in? Show . I-Mab Biopharma I-Mab is a …See details»
C-Bridge Capital - Updates, News, Events, Signals & Triggers
C-Bridge Capital raised a new fund: C-Bridge Healthcare Fund V ($1,500,000,000) Funding Round • Dec 7, 2020 Nuance Biotech raised $181,000,000 / Series D from Beijing Konruns …See details»
Jianming Ma · Cbc Group Investment Management Ltd · 62fl, …
JIANMING MA (Registration #4845814) is an attorney in Shanghai 200040 admitted in New York State in 2010, registered with the Office of Court Administration (OCA) of New York State …See details»
C-Bridge Capital - Contacts, Employees, Board Members
C-Bridge Capital has 6 current employee profiles, including Founder & Chief Executive Officer Wei Fu. Wei Fu Founder & Chief Executive Officer Kang Lan Managing DirectorSee details»